In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...

Explore how Insilico collaborates with Servier to advance AI-driven drug discovery in oncology for unmet medical needs.

This article summarizes a discussion at LSX Biopharm America on September 11. A panel of industry experts discussed approaches to overcoming the most urgent CMC challenges during the discussion. The ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

U.S. pharmaceutical company Eli Lilly plans to disclose the top-line results of its phase 3 clinical trial for ‘remternutux,’ a new drug candidate being developed as a successor to its Alzheimer’s ...

GSK’s respiratory drug lineup spans a newly approved product for chronic obstructive pulmonary disease as well as therapeutic candidates in various stages of clinical development for treating this ...